Carregant...
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS
BACKGROUND: Treatment of feline immunodeficiency virus (FIV) infection has been hampered by the absence of a specific combination antiretroviral treatment (ART). Integrase strand transfer inhibitors (INSTIs) are emerging as a promising new drug class for HIV-1 treatment, and we evaluated the possibi...
Guardat en:
Autors principals: | , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
BioMed Central
2007
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2244644/ https://ncbi.nlm.nih.gov/pubmed/17971219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4690-4-79 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|